Skip to content
GenoLensGenoLens

DTNBP1

Chr 6p22.3

dystrobrevin binding protein 1

Aliases:
Dysbindin, My031, HPS7, DBND, BLOC1S8
MANE:
ENST00000344537.10

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Bleeding and platelet disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Inherited bleeding disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Albinism or congenital nystagmus

    BIALLELIC, autosomal or pseudoautosomal
  • Familial pulmonary fibrosis

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Hermansky-Pudlak syndrome 7

    0.67
  • Hermansky-Pudlak syndrome

    0.63
  • Hermansky-Pudlak syndrome type 7

    0.52
  • schizophrenia

    0.32
  • squamous cell carcinoma

    0.32
  • pericarditis

    0.29
  • tympanic membrane disorder

    0.29
  • tympanic membrane perforation

    0.29
  • hidradenitis

    0.29
  • muscular disease

    0.29

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Dysbindin

Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex to facilitate the transport of TYRP1 independent of AP-3 function. Plays a role in synaptic vesicle trafficking and in neurotransmitter release. Plays a role in the regulation of cell surface exposure of DRD2. May play a role in actin cytoskeleton reorganization and neurite outgrowth. May modulate MAPK8 phosphorylation. Appears to promote neuronal transmission and viability through regulating the expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signaling and influencing glutamatergic release. Regulates the expression of SYN1 through binding to its promoter. Modulates prefrontal cortical activity via the dopamine/D2 pathway

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.